SCHEMBL5873518

SCHEMBL5873518

O=C(Cl)CCc1ccccc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.49
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
GAA P10253 2/20 0.45
POLB P06746 1/20 0.45
POLQ O75417 1/20 0.45
EPHX2 P34913 2/20 0.45
IDO1 P14902 2/20 0.44
DAO P14920 1/20 0.44
MAOB P27338 2/20 0.43
MAOA P21397 1/20 0.43
NR3C2 P08235 1/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
PTGFR P43088 1/20 0.42
KDM4E B2RXH2 3/20 0.42
ATM Q13315 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7400128 0.85 HDAC1 (0.50) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL29733422 0.84 EPHX2 (0.59) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL1953231 0.84 EPHX2 (0.59) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL266248 0.82 ALDH1A1 (0.50) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL3233422 0.82 MAOB (0.50) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL30257708 0.82 ALDH1A1 (0.50) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL643492 0.81 POLQ (0.55) CNR1HDAC1HDAC8GAAPOLQ
SCHEMBL23662783 0.79 IAPP (0.53) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL21576141 0.79 POLQ (0.47) CNR1HDAC1HDAC8GAAPOLB
SCHEMBL28013327 0.79 POLB (0.55) CNR1HDAC1HDAC8GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109422749-B Pyrimidinedione derivative for inhibiting monocarboxylic acid transporter 重庆医药工业研究院有限责任公司 2023-01-24 CN disclosed
US-7084156-B2 2-Aminoquinoline compounds MERCK & CO., INC. (US) 2006-08-01 US disclosed
US-20050026915-A1 2-Aminoquinoline compounds MERCK SHARP & DOHME CORP. 2005-02-03 US disclosed
EP-1450801-A2 2-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP disclosed
WO-2003045313-A2 2-AMINOQUINOLINE COMPOUNDS MERCK & CO. INC. (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026915-A1 2-Aminoquinoline compounds MCHR1, MCHR2, MC5R CNR1 479/4885HDAC1 3475/4885HDAC8 3722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.